Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
8.69
-0.14 (-1.59%)
At close: Aug 18, 2025, 3:59 PM
8.60
-1.04%
After-hours: Aug 18, 2025, 05:27 PM EDT

Anika Therapeutics Revenue

Anika Therapeutics reported an annual revenue of $119.91M, reflecting a -28.05% growth. For the quarter ending June 30, 2025, Anika Therapeutics generated $28.22M in revenue.
Revenue (ttm)
119.91M
Revenue Growth
-28.05%
Price / Sales Ratio
2.02
Revenue / Employee
416.34K
Employees
288
Market Cap
125.29M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 119.91M -28.05%
Dec 31, 2023 166.66M +6.67%
Dec 31, 2022 156.24M +5.71%
Dec 31, 2021 147.79M +13.29%
Dec 31, 2020 130.46M +13.83%
Dec 31, 2019 114.61M +8.58%
Dec 31, 2018 105.56M -6.93%
Dec 31, 2017 113.42M +9.71%
Dec 31, 2016 103.38M +11.16%
Dec 31, 2015 93M -11.93%
Dec 31, 2014 105.59M +40.64%
Dec 31, 2013 75.08M +5.22%
Dec 31, 2012 71.36M +10.16%
Dec 31, 2011 64.78M +16.60%
Dec 31, 2010 55.56M +38.42%
Dec 31, 2009 40.14M +12.17%
Dec 31, 2008 35.78M +16.06%
Dec 31, 2007 30.83M +14.86%
Dec 31, 2006 26.84M -10.04%
Dec 31, 2005 29.84M +12.73%
Dec 31, 2004 26.47M +71.81%
Dec 31, 2003 15.4M +16.81%
Dec 31, 2002 13.19M +16.57%
Dec 31, 2001 11.31M -30.75%
Dec 31, 2000 16.34M +21.00%
Dec 31, 1999 13.5M -2.88%
Dec 31, 1998 13.9M +15.83%
Dec 31, 1997 12M +900.00%
Dec 31, 1996 1.2M -64.71%
Aug 31, 1995 3.4M -27.66%
Aug 31, 1994 4.7M +113.64%
Aug 31, 1993 2.2M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.